Hydroxychloroquine-lnduced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus  

作　　者：Wen-Ming Wang Kevin Yu Wang Tao Wang Hong-Zhong Jin Kai Fang Wen-Ming Wang;Kevin Yu Wang;Tao Wang;Hong-Zhong Jin;Kai Fang(Department of Dermatology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730 China;State University of New York Upstate Medical University,Syracuse,NY 13210,USA)

机构地区：[1]Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730 China [2]State University of New York Upstate Medical University, Syracuse, NY 13210, USA

出　　处：《Chinese Medical Journal》2018年第15期1887-1888,共2页中华医学杂志（英文版）

摘　　要：To the Editor： Hydroxychloroquine （HCQ） is commonly used in systemic lupus erythematosus （SLE）, rheumatoid arthritis, and other autoimmune disorders. We report a case of psoriasis-form erythroderma induced by HCQ in an SLE patient. Thus, rheumatologists and dermatologists should be aware of the possibility of HCQ-induced psoriasis-form lesions.To the Editor： Hydroxychloroquine （HCQ） is commonly used in systemic lupus erythematosus （SLE）, rheumatoid arthritis, and other autoimmune disorders. We report a case of psoriasis-form erythroderma induced by HCQ in an SLE patient. Thus, rheumatologists and dermatologists should be aware of the possibility of HCQ-induced psoriasis-form lesions.

分 类 号：TS262.91[轻工技术与工程—发酵工程] Q959.838[轻工技术与工程—食品科学与工程]